Decreased Serum Osteocalcin is an Independent Risk Factor for Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes

PURPOSE: The association between serum osteocalcin (OCN) levels and metabolic dysfunction-associated fatty liver disease (MAFLD) is still controversial. Moreover, few studies have explored their relationship in type 2 diabetes mellitus (T2DM) patients so far. The present study aimed to investigate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yu-Jie, Jin, Chun-Hua, Ke, Jiang-Feng, Wang, Jun-Wei, Ma, Yi-Lin, Lu, Jun-Xi, Li, Mei-Fang, Li, Lian-Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719286/
https://www.ncbi.nlm.nih.gov/pubmed/36471670
http://dx.doi.org/10.2147/DMSO.S389794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719286/
https://www.ncbi.nlm.nih.gov/pubmed/36471670
http://dx.doi.org/10.2147/DMSO.S389794

Ejemplares similares